tradingkey.logo

CeriBell Inc

CBLL
20.150USD
+0.810+4.19%
Close 02/06, 16:00ETQuotes delayed by 15 min
746.53MMarket Cap
LossP/E TTM

CeriBell Inc

20.150
+0.810+4.19%

More Details of CeriBell Inc Company

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.

CeriBell Inc Info

Ticker SymbolCBLL
Company nameCeribell Inc
IPO dateOct 11, 2024
CEOChao (Xingjuan)
Number of employees281
Security typeOrdinary Share
Fiscal year-endOct 11
Address360 N. Pastoria Avenue
CitySUNNYVALE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94085
Phone18004360826
Websitehttps://ceribell.com/
Ticker SymbolCBLL
IPO dateOct 11, 2024
CEOChao (Xingjuan)

Company Executives of CeriBell Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+6618.00%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.04M
-54000.00%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
483.50K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
87.99K
--
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Juliet Tammenoms Bakker
Ms. Juliet Tammenoms Bakker
Independent Director
Independent Director
--
--
Dr. Lucian Iancovici, M.D.
Dr. Lucian Iancovici, M.D.
Independent Director
Independent Director
--
--
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.09M
+6618.00%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.04M
-54000.00%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
483.50K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
87.99K
--
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
By BusinessUSD
Name
Revenue
Proportion
EEG headbands, point in time
17.02M
75.35%
EEG portal and Clarity subscriptions, over time
5.57M
24.65%
By RegionUSD
Name
Revenue
Proportion
United States
22.59M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
EEG headbands, point in time
17.02M
75.35%
EEG portal and Clarity subscriptions, over time
5.57M
24.65%

Shareholding Stats

Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
11.63%
TPG Capital, L.P.
10.70%
Longitude Capital Management Co., LLC
6.67%
Global Value Investment Portfolio Management Pte. Ltd.
6.38%
Red Tree Management, LLC
5.95%
Other
58.67%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
11.63%
TPG Capital, L.P.
10.70%
Longitude Capital Management Co., LLC
6.67%
Global Value Investment Portfolio Management Pte. Ltd.
6.38%
Red Tree Management, LLC
5.95%
Other
58.67%
Shareholder Types
Shareholders
Proportion
Investment Advisor
39.59%
Investment Advisor/Hedge Fund
18.89%
Private Equity
10.70%
Individual Investor
10.38%
Venture Capital
6.71%
Hedge Fund
4.41%
Research Firm
1.48%
Pension Fund
0.36%
Bank and Trust
0.21%
Other
7.28%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
202
30.92M
84.91%
-28.12K
2025Q3
202
30.95M
85.03%
-25.06K
2025Q2
178
30.95M
75.12%
+1.98M
2025Q1
151
30.66M
70.71%
+5.27M
2024Q4
110
29.39M
58.97%
+8.25M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
4.31M
11.63%
-376.91K
-8.04%
Sep 30, 2025
TPG Capital, L.P.
3.97M
10.7%
--
--
Sep 30, 2025
Longitude Capital Management Co., LLC
2.48M
6.67%
+2.48M
--
Oct 16, 2024
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.38%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
5.95%
--
--
Sep 30, 2025
Parvizi (Josef)
2.09M
5.64%
+6.62K
+0.32%
Apr 11, 2025
Ally Bridge Group (HK) Limited
1.69M
4.56%
-750.00K
-30.72%
Dec 09, 2025
BlackRock Institutional Trust Company, N.A.
1.52M
4.09%
+146.63K
+10.70%
Sep 30, 2025
The Vanguard Group, Inc.
1.47M
3.97%
+147.01K
+11.09%
Sep 30, 2025
Chao (Xingjuan)
1.10M
2.96%
--
--
Dec 04, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Neuroscience and Healthcare ETF
0.57%
Hypatia Women CEO ETF
0.5%
Fidelity Fundamental Small-Mid Cap ETF
0.1%
iShares Micro-Cap ETF
0.06%
ProShares Hedge Replication ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
View more
iShares Neuroscience and Healthcare ETF
Proportion0.57%
Hypatia Women CEO ETF
Proportion0.5%
Fidelity Fundamental Small-Mid Cap ETF
Proportion0.1%
iShares Micro-Cap ETF
Proportion0.06%
ProShares Hedge Replication ETF
Proportion0.02%
iShares Russell 2000 Growth ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI